Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $13.44 USD
Change Today +0.18 / 1.36%
Volume 860.9K
SUPN On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jack A. Khattar

Founder, Chief Executive Officer, President, Secretary and Director, Supernus Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 2 different industries.

See Board Relationships
53$1,651,133
As of Fiscal Year 2014

Background*

Mr. Jack A. Khattar Founded Supernus Pharmaceuticals, Inc. (Formerly, Shire Laboratories, Inc.) and has been its Chief Executive Officer and President since 2005. Mr. Khattar serves as Secretary of Supernus Pharmaceuticals, Inc. Mr. Khattar served as President and Chief Executive Officer of Shire Pharmaceuticals Group plc since May 1999. Mr. Khattar has 19 years of industry experience in the development and commercialization of pharmaceutical products and drug delivery ...

Read Full Background

Corporate Headquarters*

1550 East Gude Drive
Rockville, Maryland 20850

United States

Phone: 301-838-2500
Fax: --

Board Members Memberships*

2005-Present
Founder, Chief Executive Officer, President, Secretary and Director

Education*

MBA
University of Pennsylvania - The Wharton School
BBA
American University of Beirut

Other Affiliations*

Annual Compensation*

Salary$485,714
Total Annual Compensation$485,714

Stock Options*

All Other Compensation$14,901
Exercisable Options75,000
Unexercisable Options375,000
Total Number of Options450,000

Total Compensation*

Total Annual Cash Compensation$792,615
Total Short Term Compensation$485,714
Other Long Term Compensation$14,901
Total Calculated Compensation$1,651,133
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SUPN:US $13.44 USD +0.18

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$470.4K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Alessandro E. Della Chà LL.MChief Executive Officer and Director
Cosmo Pharmaceuticals S.p.A.
€1.9M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUPERNUS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.